Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001322075 | SCV001512931 | benign | Noonan syndrome 9 | 2023-12-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002357153 | SCV002621841 | uncertain significance | Cardiovascular phenotype | 2022-05-09 | criteria provided, single submitter | clinical testing | The p.S1315L variant (also known as c.3944C>T), located in coding exon 23 of the SOS2 gene, results from a C to T substitution at nucleotide position 3944. The serine at codon 1315 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV001322075 | SCV002762965 | uncertain significance | Noonan syndrome 9 | criteria provided, single submitter | clinical testing |